Peripheral monoamines and CCK 4 -induced panic attacks in healthy subjects

By Jerabek I.   Boulenger J.P.   Jolicoeur F.B.   Bradwejn J.   Drumheller A.   Lavalleacute e Y.J.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 364-364

Elsevier

Access to resources Recommend Favorite

CCK 4 -induced panic in healthy subjects II: neurochemical correlates

By Jerabek I.   Boulenger J.-P.   Bradwejn J.   Andrea Drumheller   Lavallee Y.-J.   Jolicoeur F.B.  

European Neuropsychopharmacology, Vol. 9, Iss. 1, 1999-01 ,pp. : 157-164

Elsevier

Access to resources Recommend Favorite

Cholecystokinin (CCK) and C-Terminal Fragments of CCK: Effects of CCK-33, CCK-8 and CCK-4 in the Cardiovascular System of Diabetic Rats

By Wisniewska R.J.   Wisniewski K.  

General Pharmacology, Vol. 27, Iss. 2, 1996-03 ,pp. : 399-405

Elsevier

Access to resources Recommend Favorite

Cardiovascular and parasympathetic effects of dexmedetomidine in healthy subjects

By Penttilä Jani   Helminen Antti   Anttila Markku   Hinkka Susanna   Scheinin Harry  

Canadian Journal of Physiology and Pharmacology, Vol. 82, Iss. 5, 2004-05 ,pp. : 359-362

NRC Research Press

Access to resources Recommend Favorite

Would CCK-4 challenges be useful to predict anti-anxiety effects of non anti-panic drugs?

By Boulenger J.P.   Jerabek I.   Cocirc teacute G.   Lavalleacute e Y.J.   Jolicoeur F.B.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 374-375

Elsevier

Access to resources Recommend Favorite